Ionis Pharmaceuticals, Inc.
NASDAQ: IONS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Brett Monia
- Employees
- 1,069
- Headquarters
- Carlsbad, United States
- IPO year
- 1991
- Market cap
- $12.2B
- Website
- https://www.ionispharma.com
Loading IONS…
Loading profile data…Frequently asked questions about IONS
What does Ionis Pharmaceuticals, Inc. (IONS) do?
Founded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapies within the United States. Its commercial portfolio includes three key medications: SPINRAZA, prescribed for spinal muscular atrophy (SMA) in both children an...
Where does IONS trade?
Ionis Pharmaceuticals, Inc. (IONS) trades on the NASDAQ Global Select.
What sector is IONS in?
Ionis Pharmaceuticals, Inc. (IONS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Ionis Pharmaceuticals, Inc.?
Brett Monia is the chief executive officer of Ionis Pharmaceuticals, Inc. (IONS).
Where is Ionis Pharmaceuticals, Inc. headquartered?
Ionis Pharmaceuticals, Inc. is headquartered in United States.
Does IONS pay a dividend?
Ionis Pharmaceuticals, Inc. (IONS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IONS go public?
Ionis Pharmaceuticals, Inc. (IONS) completed its initial public offering in 1991.